These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 11498161

  • 21. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
    Kehinde EO, Wheatley T, Feehally J, Nicholson ML, Veitch PS, Bell PR.
    Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684
    [No Abstract] [Full Text] [Related]

  • 22. Preventive OKT3 treatment with cyclosporine (Sandimmun) for second kidney transplantation.
    Perner F, Alföldy F, Járay J, Hidvégi M, Hemangshu P.
    Transpl Int; 1994 Jun; 7 Suppl 1():S255-8. PubMed ID: 11271218
    [Abstract] [Full Text] [Related]

  • 23. Long-term follow-up (5 and 10 years) in recipients of HLA identical living related donor kidney grafts receiving continuous cyclosporine compared with azathioprine.
    MacDonald AS, Belitsky P, Bitter-Suermann H, Lawen J, MacSween M, Kiberd B, West K, McAlister VC.
    Transplant Proc; 1997 Jun; 29(1-2):190. PubMed ID: 9122958
    [No Abstract] [Full Text] [Related]

  • 24. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
    Toda F, Tanabe K, Tokumoto T, Ishikawa N, Koga S, Ito S, Yagisawa T, Toma H.
    Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909
    [No Abstract] [Full Text] [Related]

  • 25. Effect of glucocorticoid-free immunosuppressive protocol on serum lipids in renal transplant patients.
    Nowacka-Cieciura E, Soluch L, Cieciura T, Lewandowska D, Durlik M, Shaibani B, Serafinowicz A, Szmidt J, Rowiński W, Lao M.
    Transplant Proc; 2000 Sep; 32(6):1339-43. PubMed ID: 10995973
    [No Abstract] [Full Text] [Related]

  • 26. Evaluation of various immunosuppressive regimes in second renal transplants.
    Toronyi E, Remport A, Járay J, Máthé Z, Borka P, Perner F.
    Transplant Proc; 2001 May; 33(3):2315-6. PubMed ID: 11377543
    [No Abstract] [Full Text] [Related]

  • 27. Conversion of stable renal allografts from CyA to azathioprine: a 5-year follow-up.
    McLean A, Fernando O, Varghese Z, Sweny P.
    Transplant Proc; 1997 May; 29(1-2):285. PubMed ID: 9122997
    [No Abstract] [Full Text] [Related]

  • 28. Living-related kidney transplantation using low-dose triple immunosuppression.
    Rashid HU, Rahman M, Wahab MA, Kibria G, Rahman S, Jinnat S.
    Transplant Proc; 1994 Aug; 26(4):2089. PubMed ID: 8066680
    [No Abstract] [Full Text] [Related]

  • 29. Posttransplant serum creatinine area under the curve predicts renal allograft outcome.
    Sumrani N, Hong J, Miles A, Markell M, Distant D, Fleishhacker J, Maursky V, Jean-Baptiste F, Sommer B.
    Transplant Proc; 1996 Feb; 28(1):356-7. PubMed ID: 8644260
    [No Abstract] [Full Text] [Related]

  • 30. Early experience with simulect (basiliximab) induction in living donor renal allografting in India.
    Siwach V, Dhanda R, Aggarwal B, Singh B, Jain PK, Sarin PK.
    Transplant Proc; 2003 Feb; 35(1):196-7. PubMed ID: 12591364
    [No Abstract] [Full Text] [Related]

  • 31. Donor-specific transfusion in living-related renal transplants.
    Basri N, Nezamuddin N, Aman H, Banqash H, Sharwani N.
    Transplant Proc; 1992 Oct; 24(5):1746. PubMed ID: 1412822
    [No Abstract] [Full Text] [Related]

  • 32. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

  • 33. Cadaveric renal transplantation with cyclosporine monotherapy.
    Aikawa A, Sells RA, Bakran A, Tewari A.
    Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
    [No Abstract] [Full Text] [Related]

  • 34. Donor-specific transfusion for kidney transplantation in the cyclosporine era.
    Inoue S, Aikawa M, Dobashi Y, Kuzuhara K, Yanagisawa T, Ootubo O, Mimura N.
    Transplant Proc; 1996 Jun; 28(3):1220-1. PubMed ID: 8658633
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T, Kapischke M, Busing M.
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [Abstract] [Full Text] [Related]

  • 37. Long-term results in mizoribine-treated renal transplant recipients: a prospective, randomized trial of mizoribine and azathioprine under cyclosporine-based immunosuppression.
    Tanabe K, Tokumoto T, Ishikawa N, Kanematsu A, Oshima T, Harano M, Inui M, Yagisawa T, Nakajima I, Fuchinoue S, Takahashi K, Toma H.
    Transplant Proc; 1999 Nov; 31(7):2877-9. PubMed ID: 10578323
    [No Abstract] [Full Text] [Related]

  • 38. Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.
    Kokado Y, Takahara S, Kyo M, Ichimaru N, Toki K, Wang JD, Okuyama A.
    Transplant Proc; 1999 Nov; 31(1-2):1151-4. PubMed ID: 10083515
    [No Abstract] [Full Text] [Related]

  • 39. Kidney transplantation in pediatric population.
    Mota C, Henriques C, Sarmento M, Pereira E, Xavier E, Pereira M.
    Transplant Proc; 1994 Oct; 26(5):2768-70. PubMed ID: 7940872
    [No Abstract] [Full Text] [Related]

  • 40. Renal recipients of haploidentical living donors treated with Neoral or conventional cyclosporine: a comparative follow-up of 3 years.
    Gracida C, Melchor JL.
    Transplant Proc; 1998 Aug; 30(5):1742-3. PubMed ID: 9723262
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.